Compare Ginkgo Bioworks Holdings Inc (DNA) vs HP Inc (HPQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs HP Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $13 (market cap $763.64M), while HP Inc trades at $30.2 (market cap $29.25B). The key difference: HP Inc is far larger — about 38.3× Ginkgo Bioworks Holdings Inc's market cap, and HP Inc pays a 3.7% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and HP Inc for 69 Days on average.
| DNA | HPQ | |
|---|---|---|
Market Cap | $763.64M | $29.25B |
Volume | 3,204,177 | 10,025,806 |
Sector | Health | Technology |
52-Week High | $15.83 | $35.48 |
52-Week Low | $5.48 | $18.20 |
Typical Hold Time | 7 Days | 69 Days |
Enterprise Value | $865.59M | $35.42B |
Dividend Yield | — | 3.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $11.34, down 1.13% on the day, with a bullish technical signal from moving averages. The company reported a net loss of $312.76 million on $170.16 million revenue for 2025, with negative cash flow. Recent news includes a $17.5 million ARPA-H subcontract for RNA medicine manufacturing, highlighting ongoing strategic initiatives despite financial challenges.
The outlook remains speculative given persistent losses and cash burn, though analyst consensus is divided. Key risks include execution on revenue growth and path to profitability. Upside depends on successful commercialization of its biotech platform and partnerships, but high volatility and fundamental weakness warrant caution for investors.
HPQ trades at $32.44, up 0.62% with a bullish technical signal. The stock shows strong earnings momentum with three consecutive quarterly beats and maintains solid cash flow generation of $460M in 2025. Valuation appears attractive with P/E of 12.38 and P/S of 0.51, though the company faces headwinds from projected PC market declines in 2027.
HPQ offers value characteristics with reasonable valuation metrics and consistent dividend payments, but faces significant business risks from PC market contraction. Analyst sentiment is mixed with 30.8% buy ratings versus 53.8% holds, reflecting uncertainty about growth prospects amid industry challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About HP Inc
HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.
Read more on HPQ →
